ArticleFrontiers in pharmacology2024

The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system.

Wei Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.